Delivery Order SPE2DB22D2206-SPE2DB24FJH23

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,152.79 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,193.38 Firm Fixed Price Delivery Order is for the supply of 4566088090 CYCLOSPORINE 0.05% EYE EMULS 60S and has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,593.29 firm fixed-price delivery order is for the supply of 4563283579 - CYCLOSPORINE 0.05% EYE EMULS 30S, with a period of performance through January 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.16 firm fixed price delivery order is for the supply of 4565747846 ! CYCLOSPORINE 0.05% EYE EMULSION 30S. The contract has a period of performance through September 11, 2024 and was awarded on September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,342.51 firm fixed price delivery order is for the supply of 4563175324 - CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. The contract has an ultimate completion date of December 26, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,299.90 firm-fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULSION 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $9,858.80. The contract is for the delivery of cyclosporine 0.05% eye emulsion, a pharmaceutical product used in the treatment of eye conditions. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $2,650.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The contract has an ultimate completion date of August 31, 2023 and was awarded on August 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,557.90 firm fixed-price delivery order contract is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a medical product. The contract has a completion date of May 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $1,157.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which does not have a set-aside designation, is a delivery order for 4567237402 CYCLOSPORINE 0.05% EYE EMULS 30S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJH23
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,531.23 firm fixed price Delivery Order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. The contract has an ultimate completion date of July 22, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order award is part of that broader IDC.

The contract award did not utilize any set-aside designations, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, particularly the DLA and Department of Justice, AmerisourceBergen has demonstrated the ability to meet the government's requirements through these contract vehicles.

Generated 5/17/25, 9:58 AM